Cargando…

SIX1 Predicts Poor Prognosis and Facilitates the Progression of Non-small Lung Cancer via Activating the Notch Signaling Pathway

Background: Many transcription factors involved in embryonic development and reactivated in tumors are considered potential prognostic biomarkers and novel therapeutic targets in various cancers. Sine oculis homeobox homolog 1 (SIX1), a developmentally restricted transcriptional regulator, plays a c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Shanshan, Lin, Wanling, Wang, Lei, Gao, Yuan, Yuan, Xun, Zhang, Peng, Chen, Yuan, Chu, Qian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771509/ https://www.ncbi.nlm.nih.gov/pubmed/35069900 http://dx.doi.org/10.7150/jca.61385

Ejemplares similares

Meta-analysis reveals the correlation of Notch signaling with non-small cell lung cancer progression and prognosis
por: Yuan, Xun, et al.
Publicado: (2015)

Expression of Notch1 Correlates with Breast Cancer Progression and Prognosis
por: Yuan, Xun, et al.
Publicado: (2015)

Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application
por: Yuan, Xun, et al.
Publicado: (2014)

MEOX1 Promotes Tumor Progression and Predicts Poor Prognosis in Human Non-Small-Cell Lung Cancer
por: Sun, Lichao, et al.
Publicado: (2019)

Notch signaling pathway: architecture, disease, and therapeutics
por: Zhou, Binghan, et al.
Publicado: (2022)

Overexpressed C14orf166 associates with disease progression and poor prognosis in non-small-cell lung cancer
por: Zhou, Yan-Wu, et al.
Publicado: (2018)

High serum haptoglobin level is associated with tumor progression and predicts poor prognosis in non-small cell lung cancer
por: Lu, Jianjun, et al.
Publicado: (2016)

Correlation of SIDT1 with Poor Prognosis and Immune Infiltration in Patients with Non-Small Cell Lung Cancer
por: Tian, Yubin, et al.
Publicado: (2022)

Expression of Cripto‐1 predicts poor prognosis in stage I non‐small cell lung cancer
por: Xu, Chunhua, et al.
Publicado: (2020)

ZNF452 facilitates tumor proliferation and invasion via activating AKT-GSK3β signaling pathway and predicts poor prognosis of non-small cell lung cancer patients
por: Zhang, Xiupeng, et al.
Publicado: (2017)

Cytoplasmic Kaiso is associated with poor prognosis in non-small cell lung cancer
por: Dai, Shun-Dong, et al.
Publicado: (2009)

LINC02323 facilitates development of lung squamous cell carcinoma by miRNA sponge and RBP dysregulation and links to poor prognosis
por: Wu, Kuan‐Li, et al.
Publicado: (2022)

Downregulation of long non-coding RNA LET predicts poor prognosis and increases Notch signaling in non-small cell lung cancer
por: Li, Shengwen, et al.
Publicado: (2017)

Downregulation of castor zinc finger 1 predicts poor prognosis and facilitates hepatocellular carcinoma progression via MAPK/ERK signaling
por: Wang, Ji-Long, et al.
Publicado: (2018)

A narrative review of the role of the Notch signaling pathway in rheumatoid arthritis
por: Zhuang, Yue, et al.
Publicado: (2022)

Emerging roles of Nrf2 signal in non-small cell lung cancer
por: Tian, Yijun, et al.
Publicado: (2016)

NOTCH4 Is a Novel Prognostic Marker that Correlates with Colorectal Cancer Progression and Prognosis
por: Wu, Guiyang, et al.
Publicado: (2018)

CDK14 expression is elevated in patients with non-small cell lung cancer and correlated with poor prognosis
por: Yang, Yong, et al.
Publicado: (2021)

The Downregulation of LSAMP Expression Promotes Lung Cancer Progression and Is Associated with Poor Survival Prognosis
por: Chang, Chao-Yuan, et al.
Publicado: (2021)

Aurora-A contributes to cisplatin resistance and lymphatic metastasis in non-small cell lung cancer and predicts poor prognosis
por: Xu, Jie, et al.
Publicado: (2014)

Overexpression of Notch3 is associated with metastasis and poor prognosis in osteosarcoma patients
por: Tang, Xue-Feng, et al.
Publicado: (2019)

FAM83A Promotes Lung Cancer Progression by Regulating the Wnt and Hippo Signaling Pathways and Indicates Poor Prognosis
por: Zheng, Yi-Wen, et al.
Publicado: (2020)

Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma
por: Li, Mei-Xiang, et al.
Publicado: (2021)

High GNG4 expression is associated with poor prognosis in patients with lung adenocarcinoma
por: Zhou, Bodong, et al.
Publicado: (2021)

Non-small-cell lung carcinoma: role of the Notch signaling pathway
por: Barse, Levi, et al.
Publicado: (2015)

Notch and TGFβ: Functional partners facilitating tumor progression
por: Ohnuki, Hidetaka, et al.
Publicado: (2014)

Overexpression of AMPD2 indicates poor prognosis in colorectal cancer patients via the Notch3 signaling pathway
por: Gao, Qi-Zhong, et al.
Publicado: (2020)

The Notch Pathway in Breast Cancer Progression
por: Kontomanolis, Emmanuel N., et al.
Publicado: (2018)

Overexpression of PLOD3 promotes tumor progression and poor prognosis in gliomas
por: Tsai, Chia-Kuang, et al.
Publicado: (2018)

SLC6A8 is involved in the progression of non-small cell lung cancer through the Notch signaling pathway
por: Feng, Yan, et al.
Publicado: (2021)

Notch intracellular domain regulates glioblastoma proliferation through the Notch1 signaling pathway
por: Wang, Yixuan, et al.
Publicado: (2021)

Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19
por: Li, Mingyue, et al.
Publicado: (2020)

Overexpression of Musashi-1 protein is associated with progression and poor prognosis of gastric cancer
por: Shou, Zhangxuan, et al.
Publicado: (2017)

MAPK4 predicts poor prognosis and facilitates the proliferation and migration of glioma through the AKT/mTOR pathway
por: Ren, Jing, et al.
Publicado: (2023)

UBR5 oncogene as an indicator of poor prognosis in gastric cancer
por: Ding, Fanghui, et al.
Publicado: (2020)

Btbd7 contributes to reduced E-cadherin expression and predicts poor prognosis in non-small cell lung cancer
por: Fan, Chuifeng, et al.
Publicado: (2014)

Notch1 phenotype and clinical stage progression in non-small cell lung cancer
por: Nguyen, Dat, et al.
Publicado: (2015)

Downregulation of m(6)A reader YTHDC2 promotes tumor progression and predicts poor prognosis in non‐small cell lung cancer
por: Sun, Shulei, et al.
Publicado: (2020)

Increased Six1 expression is associated with poor prognosis in patients with osteosarcoma
por: Chao, Lemeng, et al.
Publicado: (2017)

Upregulation of AKIP1 contributes to metastasis and progression and predicts poor prognosis of patients with colorectal cancer
por: Jiang, Weifang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_h83nto2no0s507dtdav3fqqsuk